Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q2 2026

Biotricity Q2 2026 Results: Net Loss of $808K, Loss Widens

Biotricity Inc. reported revenue of $8.61 million for the six months ended September 30, 2026, a 11% increase year-over-year. Despite achieving positive income from operations of $0.50 million, the company recorded a net loss attributable to common stockholders of $2.02 million due to significant interest expenses and derivative liability adjustments.

Q2 2026 at a glance · $ million
MetricQ2 2026Q2 2025
Revenue4.33.9
Gross profit3.63.2
Profit before tax-0.8-0.7
Net income-0.8-0.7
EPS (diluted, $ a share)$-0.05$-0.03

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+11.5%
Gross margin83.3%
Operating margin7.8%
Source

10-Q filed with the SEC, OTC: BTCY. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Biotricity Inc.: key numbers

Share price
$0.0521Close, Nov 16
Market cap
$1.13M
Shares outstanding
21.63MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Biotricity Inc.

All →
6:01 AM ET 8-K
Leadership Change

Biotricity Leadership Change

Jainal Bhuiyan resigned as a member of the Board of Directors and the Compensation Committee of Biotricity Inc., effective September 22, 2026. The company stated the resignation was not due to any disagreement, and Ronald McClurg was appointed to fill the vacancy on the Compensation Committee.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.